News|Articles|June 2, 2025

Ophthalmology Month in Review: May 2025

This May was characterized by HCPLive’s coverage of the ARVO and Envision conferences, as well as a slew of FDA approvals towards the end of the month.

May was a busy start to the summer, both for regulatory and research news in ophthalmology. The US Food and Drug Administration (FDA) gave a slew of approvals and clearances towards the end of the month: immunoglobulin eye drops received the Investigational New Drug (IND) clearance, and Susvimo and acoltremon ophthalmic solution were approved for diabetic retinopathy and dry eye disease (DED) respectively.